GlassScriptPhysician profile
Bethany M Campbell
NPI 1932341708
$3,992.47
in general payments reported to CMS, 2019-2025
48 companies · $366 in 2025
The $366 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $315 · 2021: $903 · 2022: $837 · 2023: $674 · 2024: $299 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,226 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,226.07 |
| Education | $113.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $797.10 | 2019-2024 | Lo Loestrin Fe, Vraylar |
| Evofem Biosciences, INC. | $320.47 | 2021-2025 | Phexxi, Solosec, Phexx |
| Boston Scientific Corporation | $252.81 | 2022-2025 | Rhythmia Mapping System, Farapulse, Wavewriter Alpha Prime 16 |
| Hologic Sales and Service, LLC | $238.30 | 2019-2024 | Aptima, Myosure Tissue Removal Device, Omni Hysteroscope |
| Pfizer INC. | $210.56 | 2019-2024 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $191.53 | 2019 | |
| Coopersurgical, INC. | $152.11 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $146.02 | 2021-2025 | |
| Astellas Pharma US INC | $145.08 | 2019-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $123.31 | 2019-2023 | Slynd |
| Millicent US INC | $109.35 | 2023-2024 | Intrarosa, Femring |
| Bayer Healthcare Pharmaceuticals INC. | $107.51 | 2019-2025 | |
| Scynexis, INC. | $79.84 | 2022 | |
| Mylan Pharmaceuticals INC. | $71.49 | 2020-2022 | |
| Conmed Corporation | $65.33 | 2019-2024 | Airseal |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.